QGel raises $12 mln
QGel said Dec. 12 that it closed a $12 million financing round. The round was led by new private investors, and includes continued participation from existing investors. QGel, of Lausanne, Switzerland, is a biomaterials company that is developing synthetic gels for 3D in vitro growth of miniature human organs and tumors that mimic original organs and tumors in certain structure and functions.
12 December 2016•3 mins read
